Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Dragonfly Therapeutics
Scientific Title
A Phase 1/1b, First-In-Human, Multi-Part, Open-Label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of DF6215 in Patients With Advanced (Unresectable, Recurrent, or Metastatic) Solid Tumors